Conference News

NKF 2025 Sparsentan Provides Better Proteinuria Reduction in FSGS A post-hoc analysis of the DUPLEX trial shows significantly greater improvements in proteinuria-related outcomes vs irbesartan for tough-to-treat FSGS.
News, April 11, 2025
NKF 2025 Chlorthalidone Increases Kidney Stone Recurrence A secondary analysis of the DCP shows that, compared with hydrochlorothiazide, chlorthalidone significantly increases the risk of kidney stones — but only among those with prior stones.
News, April 11, 2025
ATTD 2025 GLP-1s Eyed as Key to Managing T1D With Obesity As obesity rates rise among individuals with T1D, GLP-1 agonist medications, indicated for T2D and weight loss, are increasingly viewed as adjuncts to insulin.
News, April 11, 2025
AAN 2025 Novel Agent for AD Agitation Continues to Show Promise Continued treatment with AXS-05, a combination of dextromethorphan and bupropion, significantly reduces the risk for recurrence of Alzheimer’s disease–related agitation, phase 3 results show.
News, April 11, 2025
AAD 2025 As Dermatology Continues to Grow, Pediatric Derm Numbers Lag Pediatric dermatologists love what they do but struggle to attract others to their subspecialty.
News, April 11, 2025
ACP-IM 2025 Eye-Opening Updates in Insomnia and OSA Expert shares treatment approaches for insomnia and alternatives for patients With PAP-intolerance.
News, April 11, 2025
AAN 2025 Prenatal Folic Acid May Boost Brain Health in Offspring Taking folic acid early in pregnancy is safe, even at high doses, and associated with improved neuropsychological outcomes in the offspring at age 6 years.
News, April 11, 2025
WCM-EADO 2025 Harnessing the Microbiome to Treat Melanoma: Can It Work? Researchers are exploring strategies to alter the gut microbiome to improve patients’ responses to immunotherapy. New research provide encouraging, but very early, data.
News, April 10, 2025
AAN 2025 AI-Powered Wearable Calms Essential Tremor The Felix NeuroAI wristband delivers tailored and dynamic electrical stimulation to the ulnar, median, and radial nerves throughout the day to relieve essential tremor.
News, April 10, 2025
AAN 2025 Inebilizumab Effective Up to 52 Weeks in Myasthenia Gravis Inebilizumab, a first-in-class CD19+ B-cell–targeting agent, is safe and effective for up to 1 year in patients with generalized myasthenia gravis, a phase 3 trial suggests.
News, April 10, 2025
ACC 2025 Rivaroxaban Comparable to Warfarin for LV Thrombus Post-MI The direct oral anticoagulant is an effective alternative to warfarin that offers predictable dosing without the need for routine monitoring in patients with STEMI, the RIVAWAR trial shows.
News, April 10, 2025
AAN 2025 First-in-Class Digital Therapeutic Effective for Migraine Adding an investigational prescription digital therapeutic to standard medication is linked to fewer migraine days than an add-on digital sham, a new phase 3 trial suggests.
News, April 09, 2025
WCM-EADO 2025 Is Drug Holiday Safe in Metastatic Melanoma? Good response rates were seen even after immunotherapy re-initiation following a drug holiday.
News, April 09, 2025
ACC 2025 So Far, TAVI Device for Aortic Regurgitation Is Effective A device in clinical development appears to be far safer and more effective than the TAVI devices currently being used off-label for the treatment of aortic regurgitation.
News, April 09, 2025
WCM-EADO 2025 Confirmed Benefit of Adjuvant Therapy in Stage III Melanoma Real-world data show that adjuvant therapy, not complete nodal dissection, is crucial for preventing relapse in patients with stage III melanoma.
News, April 09, 2025
WCM-EADO 2025 Rising Skin Cancer Rates: Epidemic or Overdiagnosis? While skin cancer rates are growing in many parts of the world, experts disagree on whether this represents a true epidemic or overdiagnosis is a contributing factor.
News, April 09, 2025
ATTD 2025 Continuous Ketone Monitoring: Essential or Optional? Two endocrinologists who live with type 1 diabetes debate this issue at the Advanced Technologies & Treatments for Diabetes (ATTD) 2025 meeting.
News, April 09, 2025
ACC 2025 Private Equity Booms in Cardiology The cost of heart disease and high-priced procedures are fueling a surge in private equity–acquired cardiovascular outpatient practices and experts discuss how this is affecting patients.
News, April 09, 2025
ACC 2025 Novel Drug Moving Forward for Lp(a) A single dose of an siRNA molecule reduces elevated lipoprotein(a) — a major, but to date, largely untreatable risk factor for cardiovascular disease — a phase 2 trial shows.
News, April 08, 2025
AAN 2025 Transnasal Cooling Promising for Migraine Delivering room-temperature air through the nose to cool the sphenopalatine ganglion taps into a powerful neuromodulatory pathway to relieve acute migraine pain, early data showed.
News, April 08, 2025

No Results